EUVIMEDEUVIMED entdecken
Crossref

Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice

Mengyuan Fu, Matthew Andersen, Reshma Ramachandran, Karina M. Berg, Joseph S. Ross

JAMA · 18.11.2026

DOI: 10.1001/jama.2026.23534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, online erschienen am 18.11.2026. Verfasst von Mengyuan Fu und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This cohort study examines the rates of blood-based biomarker testing for Alzheimer disease in US clinical practice, exploring patient characteristics, ordering clinician specialty, and diagnostic and treatment events.

Zitieren

APA

Fu, M., Andersen, M., Ramachandran, R., Berg, K. M., & Ross, J. S. (2026). Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice. JAMA. https://doi.org/10.1001/jama.2026.23534

Vancouver

Fu M, Andersen M, Ramachandran R, Berg KM, Ross JS. Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice. JAMA. 2026. doi:10.1001/jama.2026.23534

BibTeX
@article{Fu2026,
  author = {Fu, Mengyuan and Andersen, Matthew and Ramachandran, Reshma and Berg, Karina M. and Ross, Joseph S.},
  title = {Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice},
  journal = {JAMA},
  year = {2026},
  doi = {10.1001/jama.2026.23534}
}
Kostenlos starten →